QQQ   312.93 (-1.72%)
AAPL   123.71 (-1.13%)
MSFT   230.06 (-1.63%)
FB   257.30 (-0.66%)
GOOGL   2,034.62 (-1.45%)
TSLA   679.37 (-1.03%)
AMZN   3,045.54 (-1.58%)
NVDA   522.76 (-2.52%)
BABA   236.01 (+0.68%)
CGC   34.14 (-3.15%)
GE   13.35 (+2.85%)
MU   91.55 (+0.50%)
NIO   43.15 (-0.32%)
AMD   82.79 (-1.59%)
T   28.36 (+0.50%)
F   12.23 (-2.55%)
ACB   10.73 (-2.72%)
DIS   194.29 (+0.18%)
BA   230.77 (+3.42%)
NFLX   526.53 (-3.89%)
PFE   33.74 (+0.69%)
QQQ   312.93 (-1.72%)
AAPL   123.71 (-1.13%)
MSFT   230.06 (-1.63%)
FB   257.30 (-0.66%)
GOOGL   2,034.62 (-1.45%)
TSLA   679.37 (-1.03%)
AMZN   3,045.54 (-1.58%)
NVDA   522.76 (-2.52%)
BABA   236.01 (+0.68%)
CGC   34.14 (-3.15%)
GE   13.35 (+2.85%)
MU   91.55 (+0.50%)
NIO   43.15 (-0.32%)
AMD   82.79 (-1.59%)
T   28.36 (+0.50%)
F   12.23 (-2.55%)
ACB   10.73 (-2.72%)
DIS   194.29 (+0.18%)
BA   230.77 (+3.42%)
NFLX   526.53 (-3.89%)
PFE   33.74 (+0.69%)
QQQ   312.93 (-1.72%)
AAPL   123.71 (-1.13%)
MSFT   230.06 (-1.63%)
FB   257.30 (-0.66%)
GOOGL   2,034.62 (-1.45%)
TSLA   679.37 (-1.03%)
AMZN   3,045.54 (-1.58%)
NVDA   522.76 (-2.52%)
BABA   236.01 (+0.68%)
CGC   34.14 (-3.15%)
GE   13.35 (+2.85%)
MU   91.55 (+0.50%)
NIO   43.15 (-0.32%)
AMD   82.79 (-1.59%)
T   28.36 (+0.50%)
F   12.23 (-2.55%)
ACB   10.73 (-2.72%)
DIS   194.29 (+0.18%)
BA   230.77 (+3.42%)
NFLX   526.53 (-3.89%)
PFE   33.74 (+0.69%)
QQQ   312.93 (-1.72%)
AAPL   123.71 (-1.13%)
MSFT   230.06 (-1.63%)
FB   257.30 (-0.66%)
GOOGL   2,034.62 (-1.45%)
TSLA   679.37 (-1.03%)
AMZN   3,045.54 (-1.58%)
NVDA   522.76 (-2.52%)
BABA   236.01 (+0.68%)
CGC   34.14 (-3.15%)
GE   13.35 (+2.85%)
MU   91.55 (+0.50%)
NIO   43.15 (-0.32%)
AMD   82.79 (-1.59%)
T   28.36 (+0.50%)
F   12.23 (-2.55%)
ACB   10.73 (-2.72%)
DIS   194.29 (+0.18%)
BA   230.77 (+3.42%)
NFLX   526.53 (-3.89%)
PFE   33.74 (+0.69%)
Log in
OTCMKTS:APNHY

Aspen Pharmacare Stock Forecast, Price & News

$9.82
+0.08 (+0.82 %)
(As of 03/2/2021 12:00 AM ET)
Add
Compare
Today's Range
$9.42
Now: $9.82
$9.82
50-Day Range
$8.82
MA: $9.57
$10.03
52-Week Range
$4.86
Now: $9.82
$10.09
Volume571 shs
Average Volume4,182 shs
Market Capitalization$4.48 billion
P/E Ratio11.98
Dividend YieldN/A
Beta1.53
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty, branded, and generic pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anaesthetics and muscle relaxants under the Anaesthetics brand; cytotoxic medicines under the Regional brand; and injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It is also involved in the contract and supply of chemical and biochemical active pharmaceutical ingredients and finished dose form pharmaceuticals for third parties. The company offers products in the form of oral solid dose, injectables, liquids, semi-solids, steriles, biologicals, and active pharmaceutical ingredients. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.
Aspen Pharmacare logo

Industry, Sector and Symbol

Industry Private households
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:APNHY
Previous SymbolNASDAQ:APNHY
CUSIPN/A
CIKN/A
Phone27-31-580-8600
Employees9,069
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.49 billion
Cash Flow$1.19 per share
Book Value$9.77 per share

Profitability

Miscellaneous

Market Cap$4.48 billion
Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.82 out of 5 stars

Medical Sector

1051st out of 1,969 stocks

Private Households Industry

165th out of 378 stocks

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -
$9.82
+0.08 (+0.82 %)
(As of 03/2/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive APNHY News and Ratings via Email

Sign-up to receive the latest news and ratings for APNHY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Aspen Pharmacare (OTCMKTS:APNHY) Frequently Asked Questions

What stocks does MarketBeat like better than Aspen Pharmacare?

Wall Street analysts have given Aspen Pharmacare a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Aspen Pharmacare wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Aspen Pharmacare?

Aspen Pharmacare saw a increase in short interest during the month of February. As of February 12th, there was short interest totaling 600 shares, an increase of 500.0% from the January 28th total of 100 shares. Based on an average daily volume of 2,100 shares, the short-interest ratio is currently 0.3 days.
View Aspen Pharmacare's Short Interest
.

How has Aspen Pharmacare's stock price been impacted by COVID-19?

Aspen Pharmacare's stock was trading at $6.75 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, APNHY stock has increased by 45.5% and is now trading at $9.82.
View which stocks have been most impacted by COVID-19
.

Who are Aspen Pharmacare's key executives?

Aspen Pharmacare's management team includes the following people:
  • Mr. Stephen Bradley Saad, Group CEO & Exec. Director (Age 57)
  • Mr. Michael Guy Attridge, Deputy Group Chief Exec., Fin. Director & Exec. Director (Age 60)
  • Mr. Sean M. Capazorio, Group Fin. Officer (Age 54)
  • Ms. Lorraine Hill, Group Operating Officer & Responsible Pharmacist (Age 57)
  • Mr. Riaan Verster BProc, LLM, LLB, ACIS, Company Sec., Group Governance Officer & Group Compliance Officer (Age 45)
  • Mr. Stavros Nicolaou, Group Sr. Exec. of Strategic Trade (Age 56)
  • Mr. Carnie van der Linde, Group Commercial Head (Age 52)
  • Mr. Trevor Julian Ziman, Chief Exec. Officer of Asia Pacific (Age 49)
  • Mr. Samer Kassem, Chief Exec. Officer of Aspen Global Incorporated (Age 46)
  • Ms. Luresha Chetty, Corp. Affairs & Investor Relations Exec.

Who are some of Aspen Pharmacare's key competitors?

What is Aspen Pharmacare's stock symbol?

Aspen Pharmacare trades on the OTCMKTS under the ticker symbol "APNHY."

How do I buy shares of Aspen Pharmacare?

Shares of APNHY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Aspen Pharmacare's stock price today?

One share of APNHY stock can currently be purchased for approximately $9.82.

How much money does Aspen Pharmacare make?

Aspen Pharmacare has a market capitalization of $4.48 billion and generates $2.49 billion in revenue each year. The company earns $300.36 million in net income (profit) each year or $0.82 on an earnings per share basis.

How many employees does Aspen Pharmacare have?

Aspen Pharmacare employs 9,069 workers across the globe.

What is Aspen Pharmacare's official website?

The official website for Aspen Pharmacare is www.aspenpharma.com.

Where are Aspen Pharmacare's headquarters?

Aspen Pharmacare is headquartered at 9 Rydall Vale Park Douglas Saunders Drive La Lucia Ridge, Durban T3, 4051.

How can I contact Aspen Pharmacare?

Aspen Pharmacare's mailing address is 9 Rydall Vale Park Douglas Saunders Drive La Lucia Ridge, Durban T3, 4051. The company can be reached via phone at 27-31-580-8600.


This page was last updated on 3/3/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.